𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Presence of corticotropin-releasing factor-like immunoreactivity in human tumors

✍ Scribed by Ichiji Wakabayashi; Tetsuta Ihara; Makoto Hattori; Yoji Tonegawa; Tamotsu Shibasaki; Kozo Hashimoto

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
436 KB
Volume
55
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corticotropin-releasing factor (CRF) rec
Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: Protective biological role by inhibition of apoptosis
✍ Ekaterini Chatzaki; Maria Lambropoulou; Theodoros C. Constantinidis; Nikolaos Pa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

## Abstract Corticotropin‐releasing factor agonists exert inhibitory effects in stomach functions possibly through peripheral routes. We have previously reported the expression of Urocortin (Ucn) I, an endogenous ligand of both CRF receptor types CRF~1~ and CRF~2~, in the human stomach. We examined

Differential effects of stress and amphe
Differential effects of stress and amphetamine administration on Fos-like protein expression in corticotropin releasing factor-neurons of the rat brain
✍ David Rotllant; Roser Nadal; Antonio Armario 📂 Article 📅 2007 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 290 KB 👁 1 views

## Abstract Corticotropin releasing factor (CRF) appears to be critical for the control of important aspects of the behavioral and physiological response to stressors and drugs of abuse. However, the extent to which the different brain CRF neuronal populations are similarly activated after stress a

Enhanced proliferation of human fibrobla
Enhanced proliferation of human fibroblasts, in the presence of dexamethasone, is accompanied by changes in p21Waf1/Cip1/Sdi1 and the insulin-like growth factor type 1 receptor
✍ Shu Li; Madhumalti Mawal-Dewan; Vincent J. Cristofalo; Christian Sell 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

The addition of dexamethasone (dex) to human fibroblast cultures has been found to elicit enhanced proliferation. This enhancement is manifested by an increase in the initial growth rate, saturation density, and proliferative life span of WI-38 fibroblast cultures grown in the presence of dex. We ex

Inhibition of proliferation in human MNN
Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone : Effects on insulin-like growth factor II
✍ Ryszard Braczkowski; Andrew V. Schally; Artur Plonowski; Jozsef L. Varga; Kate G 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 2 views

## Abstract ## BACKGROUND Antagonists of growth hormone‐releasing hormone (GH‐RH) can inhibit the proliferation of various tumors either indirectly through the suppression of the pituitary growth hormone/hepatic insulin‐like growth factor I (__IGF‐I__) axis and the lowering of serum __IGF‐I__ conc

Epidermal growth factor (EGF) promotes c
Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone
✍ Rajan, Rishi; Vanderslice, Rick; Kapur, Shakti; Lynch, John; Thompson, Rik; Djak 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 798 KB

Prostate tumor cells preferentially metastasize to bony sites and lymph nodes at a frequency in excess of that which would be predicted by random tumor cell dissemination. In order to determine whether chemoattractants in these organs promote organ-specific metastasis, we utilized human cell lines d